×
For best experience we recommend to activate Javascript in your browser.
EIF2S1 antibody
EIF2S1
Reactivity: Human
WB, ICC, FACS, DB
Host: Mouse
Monoclonal
EIF2S1A2B8
unconjugated
Product Details anti-EIF2S1 Antibody
(hide)
Target
See all EIF2S1 Antibodies
EIF2S1
(Eukaryotic Translation Initiation Factor 2 Subunit 1 (EIF2S1))
Reactivity
All reactivities for EIF2S1 antibodies
Human
Host
All hosts for EIF2S1 antibodies
Mouse
Clonality
All clonalities for EIF2S1 antibodies
Monoclonal
Conjugate
All conjugates for EIF2S1 antibodies
This EIF2S1 antibody is un-conjugated
Application
All applications for EIF2S1 antibodies
Western Blotting (WB), Immunocytochemistry (ICC), Flow Cytometry (FACS), Dot Blot (DB)
Cross-Reactivity
Human, Mouse (Murine), Rat (Rattus)
Cross-Reactivity (Details)
Other species not studied.
Purification
Protein G affinity chromatography
Immunogen
EIF2 S1 antibody was raised in mouse using recombinant Human Eukaryotic Translation Initiation Factor 2, Subunit 1 Alpha, 32 da
Clone
EIF2S1A2B8
Isotype
IgG1
Top Product
Discover our top product EIF2S1 Primary Antibody
Alternatives
(show)
Application Details
(hide)
Application Notes
WB: 0.2-2 µg/mL, FC: 0.5-2 µg/sample, ICC: 2-100 µg/mL Optimal conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Concentration
Lot specific
Buffer
EIF2 S1 antibody in PBS (3.0 mM KCl, 1.5 mM KH2 PO4 , 140 mM NaCl, 8.0 mM Na2 HPO4 (pH 7.4)) containing 1 % bovine serum albumin (BSA) and 0.05 % sodium azide (NaN3 ).
Preservative
Sodium azide
Precaution of Use
This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Handling Advice
Avoid repeated freeze/thaw cycles. Dilute only prior to immediate use.
Storage
4 °C/-20 °C
Storage Comment
Store at 2-8 °C for up to one year. We recommend long term storage at -20 °C.
Target Details for EIF2S1
(hide)
Target
EIF2S1
(Eukaryotic Translation Initiation Factor 2 Subunit 1 (EIF2S1))
Alternative Name
EIF2S1 (EIF2S1 Products )
Synonyms
EIF-2 antibody, EIF-2A antibody, EIF-2alpha antibody, EIF2 antibody, EIF2A antibody, Eif2s1 antibody, eif2s1l antibody, fb36a08 antibody, wu:fb36a08 antibody, zgc:56510 antibody, 0910001O23Rik antibody, 2410026C18Rik antibody, 35kDa antibody, Eif2a antibody, eIF2alpha antibody, eif2a antibody, CG9946 antibody, Dmel\\CG9946 antibody, Eif2alpha antibody, IF2A_DROME antibody, M(1)14C antibody, M(1)19-153 antibody, M(1)8e3-10 antibody, deIF2alpha antibody, eIF-2 antibody, eIF-2 a antibody, eIF-2 alpha antibody, eIF2 alpha antibody, eIF2-alpha antibody, eIF2a antibody, eiF-2alpha antibody, elF2alpha antibody, l(1)14Cf antibody, l(1)19-153 antibody, eukaryotic translation initiation factor 2 subunit alpha antibody, eukaryotic translation initiation factor 2, subunit 1 alpha a antibody, eukaryotic translation initiation factor 2, subunit 1 alpha antibody, eukaryotic translation initiation factor 2 alpha subunit antibody, Eukaryotic translation initiation factor 2 subunit 1 antibody, eukaryotic translation initiation factor 2 subunit alpha L homeolog antibody, eukaryotic translation Initiation Factor 2alpha antibody, EIF2S1 antibody, eif2s1a antibody, Eif2s1 antibody, eif2s1 antibody, LOC693063 antibody, CNI00230 antibody, THAPSDRAFT_105 antibody, if2a antibody, eif2s1.L antibody, eIF-2alpha antibody
Background
The translation initiation factor eIF2 catalyzes the first regulated step of protein synthesis initiation, promoting the binding of the initiator tRNA to 40S ribosomal subunits. Binding occurs as a ternary complex of methionyl-tRNA, eIF2, and GTP. eIF2 is composed of 3 nonidentical subunits, alpha (36 kDa), beta (38 kDa, MIM 603908), and gamma (52 kDa, MIM 300161). The rate of formation of the ternary complex is modulated by the phosphorylation state of eIF2-alpha. Synonyms: Monoclonal EIF2S1 antibody, Anti-EIF2S1 antibody, Eukaryotic translation initiation factor 2 subunit 1 antibody, EIF-2A antibody, EIF-2alpha antibody, EIF-2 antibody, EIF2A antibody.
Pathways
Ribonucleoprotein Complex Subunit Organization , ER-Nucleus Signaling , Hepatitis C
Recently viewed
(hide)